Skip to main content

Research Repository

Advanced Search

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors

Demjaha, A.; Demjaha, Arsime; Lappin, J. M.; Stahl, D.; Patel, M. X.; MacCabe, J. H.; Howes, O. D.; Heslin, M.; Reininghaus, Ulrich A.; Donoghue, K.; Lomas, B.; Charalambides, M.; Onyejiaka, A.; Fearon, P.; Jones, P.; Doody, G.; Morgan, C.; Dazzan, P.; Murray, R. M.

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors Thumbnail


Authors

A. Demjaha

Arsime Demjaha

J. M. Lappin

D. Stahl

M. X. Patel

J. H. MacCabe

O. D. Howes

M. Heslin

Ulrich A. Reininghaus

K. Donoghue

B. Lomas

M. Charalambides

A. Onyejiaka

P. Fearon

P. Jones

G. Doody

C. Morgan

P. Dazzan

R. M. Murray



Abstract

Background: We examined longitudinally the course and predictors of treatment resistance in a large cohort of first-episode psychosis (FEP) patients from initiation of antipsychotic treatment. We hypothesized that antipsychotic treatment resistance is: (a) present at illness onset; and (b) differentially associated with clinical and demographic factors.
Method: The study sample comprised 323 FEP patients who were studied at first contact and at 10-year follow-up. We collated clinical information on severity of symptoms, antipsychotic medication and treatment adherence during the follow-up period to determine the presence, course and predictors of treatment resistance.
Results: From the 23% of the patients, who were treatment resistant, 84% were treatment resistant from illness onset. Multivariable regression analysis revealed that diagnosis of schizophrenia, negative symptoms, younger age at onset, and longer duration of untreated psychosis predicted treatment resistance from illness onset.
Conclusions: The striking majority of treatment-resistant patients do not respond to first-line antipsychotic treatment even at time of FEP. Clinicians must be alert to this subgroup of patients and consider clozapine treatment as early as possible during the first presentation of psychosis.

Citation

Demjaha, A., Demjaha, A., Lappin, J. M., Stahl, D., Patel, M. X., MacCabe, J. H., …Murray, R. M. (2017). Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychological Medicine, 47(11), 1981-1989. https://doi.org/10.1017/S0033291717000435

Journal Article Type Article
Acceptance Date Jan 27, 2017
Online Publication Date Apr 11, 2017
Publication Date 2017-08
Deposit Date May 4, 2017
Publicly Available Date May 4, 2017
Journal Psychological Medicine
Print ISSN 0033-2917
Electronic ISSN 1469-8978
Publisher Cambridge University Press
Peer Reviewed Peer Reviewed
Volume 47
Issue 11
Pages 1981-1989
DOI https://doi.org/10.1017/S0033291717000435
Keywords Schizophrenia, First-Episode- Psychosis, Treatment-Response, Clozapine, Treatment-Resistant
Public URL https://nottingham-repository.worktribe.com/output/855581

Files





Downloadable Citations